Kim, Y.; Yun, H.J.; Choi, K.H.; Kim, C.W.; Lee, J.H.; Weicker, R.; Kim, S.-M.; Park, K.C.
Discovery of New Anti-Cancer Agents against Patient-Derived Sorafenib-Resistant Papillary Thyroid Cancer. Int. J. Mol. Sci. 2023, 24, 16413.
https://doi.org/10.3390/ijms242216413
AMA Style
Kim Y, Yun HJ, Choi KH, Kim CW, Lee JH, Weicker R, Kim S-M, Park KC.
Discovery of New Anti-Cancer Agents against Patient-Derived Sorafenib-Resistant Papillary Thyroid Cancer. International Journal of Molecular Sciences. 2023; 24(22):16413.
https://doi.org/10.3390/ijms242216413
Chicago/Turabian Style
Kim, Yuna, Hyeok Jun Yun, Kyung Hwa Choi, Chan Wung Kim, Jae Ha Lee, Raymond Weicker, Seok-Mo Kim, and Ki Cheong Park.
2023. "Discovery of New Anti-Cancer Agents against Patient-Derived Sorafenib-Resistant Papillary Thyroid Cancer" International Journal of Molecular Sciences 24, no. 22: 16413.
https://doi.org/10.3390/ijms242216413
APA Style
Kim, Y., Yun, H. J., Choi, K. H., Kim, C. W., Lee, J. H., Weicker, R., Kim, S.-M., & Park, K. C.
(2023). Discovery of New Anti-Cancer Agents against Patient-Derived Sorafenib-Resistant Papillary Thyroid Cancer. International Journal of Molecular Sciences, 24(22), 16413.
https://doi.org/10.3390/ijms242216413